Remove Clinical Trials Remove Disease Remove Pharma R&D Remove Trials
article thumbnail

Mapping the GenAI Landscape in Pharma R&D

BenchSci

This surge has demonstrated to budget holders and decision-makers alike the significant impact AI can have when effectively applied, offering immense potential to accelerate drug discovery and development across various stages, from unraveling the complexity of disease biology to refining drug design and expediting clinical trials.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

Within the next five to 10 years, AI will fundamentally change the way drugs are designed, with the potential to produce an order of magnitude for more high-quality candidates against a broad range of new diseases. Take as an example patient recruitment, the most time-consuming part of a trial.